Company Filing History:
1 out of 832,843 Years Active: 2004
Title: Martin Gohlke: Innovator in Recombinant Glycoproteins
Introduction
Martin Gohlke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. His work focuses on the production and application of these glycoproteins in medical treatments.
Latest Patents
Gohlke holds a patent for "Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof." This invention relates to novel recombinant glycoproteins that serve as messenger substances and signaling agents in the human circulatory system. The patent details a method for producing these glycoproteins and their use in pharmaceutical agents, including various human growth factors and coagulation factors.
Career Highlights
Throughout his career, Martin Gohlke has focused on advancing the understanding and application of recombinant proteins in medicine. His innovative approach has led to the development of important therapeutic agents that can significantly impact patient care.
Collaborations
Gohlke has collaborated with esteemed colleagues such as Werner Reutter and Rudolf Tauber. These partnerships have fostered a collaborative environment that enhances research and development in the field of biotechnology.
Conclusion
Martin Gohlke's contributions to the field of recombinant glycoproteins exemplify the importance of innovation in medical science. His work continues to pave the way for new therapeutic solutions that can improve health outcomes.